Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.

Eligibility criteria

Qualifiers

Adult patient ≥18 years old

Heart transplant

Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022

Invasive aspergillosis

Disqualifiers

Patient having expressed his opposition to participating in the study

Patient not having a liver transplant

Subject under guardianship, curatorship or safeguard of justice.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed